With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.
New study shows potentiating a subset of NMDA receptors may be beneficial in Alzheimer's disease and Dravet syndrome.
Five new members join the Gladstone Foundation Board
Machine, Meet Stem Cells
New study shows how patterns in brain activity can be an early predictor of Alzheimer's symptoms
NIH award supports collaborative work to discover the connection between neurovascular dysfunction and cognitive decline in Alzheimer's disease.
Gladstone researchers Warner C. Greene and Eytan Herzig collaborated with Xyphos Biosciences, Inc., to develop a novel immunotherapy for HIV.
The biotech company MedaRed, Inc. is founded on groundbreaking basic research from Gladstone Institutes, UC San Francisco, and UC San Diego
Keller's work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine
Benoit Bruneau is selected to lead the Gladstone Institute of Cardiovascular Disease
The National Institutes of Health renews its funding of a promising internship program at the Gladstone Institutes
Basic science discovery explains a fundamental way human cells differ from yeast cells.
Study by Gladstone scientists finds blood protein destroys memory storage sites in the brain and may lead to new treatments
New study challenges a fundamental assumption of how proteins interact with the human genome
An unexpected brain region is important for Dravet Syndrome, finds study from the Gladstone Institutes
Insight into how three of the world's most devastating viruses interact with human cells opens the door for much-needed treatments
Shipman will build new technologies to understand the development of the brain
Gladstone scientists uncover new gatekeeper function of the anti-aging molecule
Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks
The NIH funds an initiative at the Gladstone Institutes to assess the safety of CRISPR-like therapies in human tissues
New discoveries about how cells self-organize could help researchers create more authentic organ models for research or transplantation
Robert Wicks appointed the new vice president of philanthropy
Gladstone researchers discover a noisy step in gene expression
Connecting the dots between human papillomavirus and smoking-related cancers
The co-inventor of CRISPR genome editing technology expands research collaborations to San Francisco's Mission Bay research community
New study from the Gladstone Institutes uncovers how the viruses bypass your body's defense mechanisms
Wernig was selected for his groundbreaking research in cellular reprogramming and stem cell-based therapies for genetic disease
Scientists from the Gladstone Institutes discover how to enhance the longevity of cells that kill tumors and infected cells
A team of scientists from the Gladstone Institutes, UCSF, and UC Berkeley identify nearly 200 potential drug targets
BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders